Astrazeneca admits its Covishield vaccine can cause a rare side effect: Learn more about this condition
The Indian Express -

According to a report by The Telegraph, AstraZeneca, the company behind the Covishield vaccine, has acknowledged in court documents for the first time that the vaccine may lead to a rare side effect. It said, “It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known." This marks a notable reversal that could lead to a multi-million pound legal payout. According to the report, the company is being sued in a class action over claims that its vaccine...

Related Articles

Latest in News

More from The Indian Express | Covishield vaccine AstraZeneca TTS Thrombosis with Thrombocytopenia Syndrome blood clots platelets side effects COVID-19 vaccine safety public health India Dr Jagadish J Hiremath Vaccine Serum Institute Of India